Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma, Xin Peng, Xin Huang, Shaolu Zhang, et al.
The KRAS Mutational Spectrum and Its Clinical Implications in Pancreatic Cancer, Luigi Perelli, Giannicola Genovese, and Giulio F Draetta
The KRAS Mutational Spectrum and Its Clinical Implications in Pancreatic Cancer, Luigi Perelli, Giannicola Genovese, and Giulio F Draetta
A Structured Curriculum Supporting Biomedical Trainees’ Transition Into Independent Academic Positions and Early Career Success, Mabel Perez-Oquendo, Gabriele Romano, David P Farris, et al.
Role of the Antiparallel Double-Stranded Filament Form of FtsA in Activating The Escherichia coli divisome, Abbigale Perkins, Mwidy Sava Mounange-Badimi, and William Margolin
Determinants of Mosaic Chromosomal Alteration Fitness, Yash Pershad, Taralynn Mack, Hannah Poisner, et al.
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Regulates Phagocytosis in Glioblastoma, Mekenzie M Peshoff, Pravesh Gupta, Shivangi Oberai, et al.
Pre-COVID-19 Hospital Quality and Hospital Response to COVID-19: Examining Associations between Risk-Adjusted Mortality for Patients Hospitalised with COVID-19 and Pre-COVID-19 Hospital Quality, Doris Peter, Shu-Xia Li, Yongfei Wang, et al.
Analysis of Microbiome Data, Christine B Peterson, Satabdi Saha, and Kim-Anh Do
Pan-Cancer Proteogenomics Characterization of Tumor Immunity, Francesca Petralia, Weiping Ma, Tomer M Yaron, et al.
The Fatigue-Inducing Effects of Cancer and Its Therapy Are Characterized by Decreased Physical Activity in the Absence of Any Motivational Deficit, Thien T Phan, Kiersten S Scott, Brandon Chelette, et al.
Subsyndromes and Symptom Clusters: Multilevel Factor Analysis of Behavioral and Psychological Symptoms of Dementia With Intensive Longitudinal Data, Carolyn E Z Pickering, Vicki Winstead, Mustafa Yildiz, et al.
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner, Phillip M Pifer, Liangpeng Yang, Manish Kumar, et al.
Phase II Study of Talazoparib in Advanced Cancers With BRCA1/2, DNA Repair, and PTEN Alterations, Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.
Phase II Study of Talazoparib in Advanced Cancers With BRCA1/2, DNA Repair, and PTEN Alterations, Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors, Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types, Patrick G Pilié, Virginia Giuliani, Wei-Lien Wang, et al.
Using Genome and Transcriptome Data From African-Ancestry Female Participants To Identify Putative Breast Cancer Susceptibility Genes, Jie Ping, Guochong Jia, Qiuyin Cai, et al.
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma: A Phase 2 Nonrandomized Controlled Trial, Chelsea C Pinnix, Bouthaina S Dabaja, Jillian R Gunther, et al.
Healthcare Resource Utilization, Costs and Treatment Associated With Myasthenia Gravis Exacerbations Among Patients With Myasthenia Gravis in the USA: A Retrospective Analysis of Claims Data, Julia Pisc, Angela Ting, Michelle Skornicki, et al.
Author Correction: BRAFV600E-Mutant Metastatic NSCLC: Disease Overview and Treatment Landscape, David Planchard, Rachel E Sanborn, Marcelo V Negrao, et al.
BRAFV600E-Mutant Metastatic NSCLC: Disease Overview and Treatment Landscape, David Planchard, Rachel E Sanborn, Marcelo V Negrao, et al.
Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell Lymphoma, Joshua P Plotnik, Adam E Richardson, Haopeng Yang, et al.
Targeted Sequencing for Hereditary Breast and Ovarian Cancer in BRCA1/2-Negative Families Reveals Complex Genetic Architecture and Phenocopies, Jocelyn N Plowman, Evanjalina J Matoy, Lavanya V Uppala, et al.
Rosiglitazone and Trametinib Exhibit Potent Anti-Tumor Activity in a Mouse Model of Muscle Invasive Bladder Cancer, Sakina A Plumber, Tiffany Tate, Hikmat Al-Ahmadie, et al.